# Damien Sanderlin, MD – FDA Inspection, Mar 29, 2012

Source: https://www.keypedia.com/records/fda_inspections/damien-sanderlin-md/b6ee764f-53bb-4b09-935f-ca1c0faf0102
Source feed: FDA_Inspections

> FDA inspection 775234 of Damien Sanderlin, MD, March 29, 2012. Classification: Official Action Indicated (OAI). 1 citation under 21 CFR part 812. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 775234
- Company Name: Damien Sanderlin, MD
- Inspection Date: 2012-03-29
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 790026 - 2012-07-18](https://www.keypedia.com/records/fda_inspections/damien-sanderlin-md/c0ef4d71-a730-4bf1-b9f9-ba6dc73fb184)

Company: https://www.keypedia.com/companies/damien-sanderlin-md/ee882a7a-e0f5-4507-a51a-8796cab9d12f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
